Succinate Predisposes Mice to Atrial Fibrillation By Impairing Mitochondrial Function Via Inactivating AMPK

Yudi Zhang,Haoyu Gong,Lingyan Jin,Jiali Fan,Peng Liu,Xinghua Qin,Qiangsun Zheng

DOI: https://doi.org/10.2139/ssrn.4405648

2023-01-01

Abstract:Atrial fibrillation (AF) is a major public health problem that confers substantial mortality and morbidity. Mitochondrial dysfunction is an important pathological feature of AF, but the underlying mechanisms and therapeutic targets are largely unraveled. Succinate, a critical mitochondrial Krebs cycle metabolite, is elevated in the plasma of individuals with AF or AF risks, yet its precise role in AF pathology remains unclear.To dissect the molecular mechanism linking succinate overloading and AF, we exposed mice (2%/5% w/v, 7 weeks) and neonatal rat cardiac fibroblasts (NRCFs) (0.5 mM, 24 hours) to succinate, and compared the AF vulnerability and atrial substrate formation. Succinate predisposed mice to AF and displayed adverse atrial remodeling, including left atrial dilation, atrial connexin disturbance, and atrial fibrosis. Mechanistically, succinate compromised mitochondrial structure/function and caused oxidative stress in the atria of mice. Pharmacologic activation of AMPK (AICAR, 0.5 mM) mitigated succinate-induced fibrosis by maintaining mitochondrial health in NRCFs. Overall, succinate overloading promotes atrial fibrosis and thus provides a substrate for AF via inactivating AMPK and resultant mitochondrial dysfunction, pointing to succinate as an underestimated mechanistic contributor and potential biomarker in AF.